MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Cervical dystonia and quality of life

    S. Tomic, I. Petkovic, T. Pucic, S. Juric, S. Butkovic Soldo (Osijek, Croatia)

    Objective: To evaluate appearance of depression and anxiety in patiens with cervical dystonia and influence of dystonia symptoms on the quality of life. Background: Cervical…
  • 2016 International Congress

    AbobotulinumtoxinA for cervical dystonia: A meta-analysis of injection practices across 5 countries

    R. Trosch, V.P. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)

    Objective: To explore national differences in the use of abobotulinumtoxinA (ABO) in the management of cervical dystonia (CD). Background: Botulinum toxin injections (including ABO) are…
  • 2016 International Congress

    Association analysis of NALCN polymorphisms rs1338041 and rs61973742 in a Chinese population with isolated cervical dystonia

    Q. Zhou, J. Yang, B. Cao, Y. Chen, Q. Wei, R. Ou, W. Song, B. Zhao, Y. Wu, H. Shang (Chengdu, People's Republic of China)

    Objective: The present study was carried out to examine the associations between the two single nucleotide polymorphisms (SNPs) rs1338041 and rs61973742 in the NALCN gene…
  • 2016 International Congress

    Assessing vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment

    K.L. Andrzejewski, A. Owens, M.T. Bull, K.M. Biglan, S. Kanchana, J.W. Mink, R. Barbano (Rochester, NY, USA)

    Objective: To determine if individuals with cervical dystonia have altered vestibular function compared to unaffected individuals, and whether botulinum toxin treatment alters those variables. Background:…
  • 2016 International Congress

    Triad-conditioning transcranial magnetic stimulation in focal hand dystonia

    T. Popa, R. Hunt, O. Ahmad, K. Mente, R. Paine, M. Hallett (Bethesda, MD, USA)

    Objective: To evaluate if the intrinsic oscillations within the primary motor cortex (M1) at rest are entrained at the same frequencies of trains of transcranial…
  • 2016 International Congress

    Finger tapping-related brain activation and impact of cerebellar theta-burst stimulation in cervical dystonia patients

    T.M. Odorfer, G.A. Homola, J. Volkmann, D. Zeller (Wuerzbuerg, Germany)

    Objective: To assess brain activation during simple movements of the right hand in patients with cervical dystonia (CD) by means of fMRI. To test the…
  • 2016 International Congress

    Parietal hand pseudodystonia: Significant functional gains with ultrasound-guided botulinum toxin treatments

    P. Pita Lobo, C. Costa (Amadora, Portugal)

    Objective: Case report. Background: Symptomatic focal dystonia is most commonly secondary to lesions involving the basal ganglia. Previous reports have documented the occurrence of focal…
  • 2016 International Congress

    Botulinum toxin type B therapy for cervical dystonia – 2015 update of a Cochrane systematic review and meta-analysis

    R.E. Marques, G.S. Duarte, F.B. Rodrigues, M. Castelão, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

    Objective: To compare the effects of botulinum toxin type B (BtB) versus placebo in cervical dystonia (CD). Background: This is an update of a Cochrane…
  • 2016 International Congress

    Localization of basal ganglia and thalamic damage in dyskinetic cerebral palsy

    B.R. Aravamuthan, J.L. Waugh (Boston, MA, USA)

    Objective: To quantitatively consolidate published reports of deep grey matter injury in cerebral palsy to determine the patterns of injury associated with dystonia and dyskinesias.…
  • 2016 International Congress

    Association of amyotrophic lateral sclerosis with basal ganglia impairment

    D. Mirzaeva, A. Prokhorova, B. Muinjanov, P. Deleyn (Tashkent, Uzbekistan)

    Objective: The aim of this study is to define extent of basal ganglia involvement in amyotrophic lateral sclerosis (ALS). Methods: The study included 45 patients…
  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Unusual prolonged survival in multiple system atrophy: A case report
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley